DESCRIPTION

This module offers a comprehensive overview of amyloidosis, focusing on ATTR-CM and its various phenotypes. It covers epidemiology and disparities in care based on geography, race, and gender. Learners will gain insights into common symptoms to help identify potential cases. Through clinical case discussions, the program will outline key steps in assessing hATTR-CM , including recognizing heart failure patients who should be evaluated for amyloidosis, accessing genetic testing resources, and supporting patients considering genetic testing. Additionally, it provides tools for effective patient communication about testing and results, including guidance on discussing findings with family members.

LEARNING OBJECTIVES

1. Identify patients with heart failure who should be assessed for possible amyloidosis work-up
2. Describe to patients with ATTR-CM how genetic testing may impact their disease management 
3. Outline steps and available resources for genetic testing for patients with ATTR-CM

PURCHASE THIS FREE COURSE